Specifically, the mRNA expression levels of RUNX2, ALP, and BSP in the EMD+OM group were significantly higher than the control and OM group at day 3, while the odontoblastic-related genes including DSPP, DMP1, and OCN were remarkably upregulated at day 14. The gene discussed is RUNX2; the disease is ocular melanoma.